Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celltech Chiroscience Acquisition Of Medeva Provides Marketing Muscle

Executive Summary

Medeva will bring a sales force of 400 reps, including 180 reps in the U.S., to the proposed merger with Celltech Chiroscience.

You may also be interested in...



The Liposome Company Moves Past Evacet Set-Backs With Elan Merger

Elan would add a 40 rep oncology sales force to market its non-opioid analgesic ziconotide with the acquisition of The Liposome Company announced March 6.

The Liposome Company Moves Past Evacet Set-Backs With Elan Merger

Elan would add a 40 rep oncology sales force to market its non-opioid analgesic ziconotide with the acquisition of The Liposome Company announced March 6.

Medeva Fluvirin Production Returns To Market-Demand Level

Production of Medeva's influenza vaccine Fluvirin has returned to levels of market demand following improvements in the manufacturing process, the company said.

Related Content

UsernamePublicRestriction

Register

PS035157

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel